CCR6 antagonist 1（Cat No.:I043118）is a small molecule inhibitor designed to target and block the CCR6 receptor, a G-protein-coupled receptor (GPCR) involved in immune cell trafficking. CCR6 is expressed on various immune cells, including T cells, dendritic cells, and macrophages, and plays a critical role in inflammatory processes and autoimmune diseases. By inhibiting CCR6, this compound aims to reduce the migration of inflammatory cells to sites of disease, potentially providing therapeutic benefits in conditions like rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. CCR6 antagonist 1 is being studied for its efficacy in modulating immune responses.